The STOP-AUST trial: a test for the spot sign in intracerebral haemorrhage

摘要

Spontaneous intracerebral haemorrhage—non-traumatic bleeding into the brain—is the least treatable and most deadly form of stroke, accounting for about 5% of all deaths and causing major disability in about 18 million survivors each year.1 By contrast with the advances in treating ischaemic stroke, there are not effective treatments for acute intracerebral haemorrhage, making it a major and urgent unmet clinical need.